SCHEMBL23958253

SCHEMBL23958253

O=c1c2ccccc2nc(Nc2cccc3nccn23)n1-c1ccccc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.42
KDM4E B2RXH2 4/20 0.42
SMN1; SMN2 Q16637 2/20 0.42
GLA P06280 1/20 0.42
GAA P10253 1/20 0.42
POLB P06746 3/20 0.41
MAPT P10636 3/20 0.41
RAB9A P51151 2/20 0.41
NPC1 O15118 1/20 0.41
PDE7A Q13946 2/20 0.40
LMNA P02545 1/20 0.40
NPY1R P25929 1/20 0.40
NPY2R P49146 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
PTGS2 P35354 1/20 0.40
MEN1 O00255 1/20 0.39
HSP90AA1 P07900 1/20 0.39
KMT2A Q03164 1/20 0.39
HPGD P15428 1/20 0.39
USP2 O75604 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24111018 0.77 MAPT (0.41) ALDH1A1KDM4ESMN1; SMN2POLBMAPT
SCHEMBL24110801 0.76 USP2 (0.43) ALDH1A1KDM4EGAAPOLBMAPT
SCHEMBL23958271 0.74 MAPT (0.43) ALDH1A1KDM4EPOLBMAPTRAB9A
SCHEMBL24110995 0.70 ALOX12 (0.57) MAPTRAB9APDE7AMEN1HSP90AA1
SCHEMBL24089980 0.69 ALDH1A1 (0.51) ALDH1A1KDM4ESMN1; SMN2GAAPOLB
SCHEMBL23958173 0.69 ALDH1A1 (0.48) ALDH1A1KDM4EGAAPOLBMAPT
SCHEMBL24111073 0.68 MAPT (0.46) ALDH1A1KDM4EPOLBMAPTRAB9A
SCHEMBL24110951 0.68 USP2 (0.44) ALDH1A1KDM4EGAAPOLBMAPT
SCHEMBL9728648 0.68 ADORA3 (0.57) KDM4EPOLBRAB9ANPC1
SCHEMBL24090010 0.68 USP2 (0.52) ALDH1A1KDM4EPOLBMAPTRAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210387967-A1 2-HETEROARYL AMINOQUINAZOLINONE DERIVATIVE SUMITOMO DAINIPPON PHARMA CO., LTD. (JP) 2021-12-16 US disclosed
WO-2021215537-A1 2-HETEROARYLAMINOQUINAZOLINONE DERIVATIVE 大日本住友製薬株式会社 (JP) 2021-10-28 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210387967-A1 2-HETEROARYL AMINOQUINAZOLINONE DERIVATIVE CRKL, CLIC4, CLIC1 ALDH1A1 1803/4885KDM4E 1401/4885SMN1; SMN2 3266/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.